Skip to main content
. 2010 Dec 8;5(12):e15482. doi: 10.1371/journal.pone.0015482

Figure 1. Model of interactions among the cellular vaccine (V), immune system and prostate cancer cells (P).

Figure 1

Dm, antigen-presenting dermal dendritic cells; DC, mature dendritic cells; DR, “exhausted” dendritic cells; R, regulatory/inhibitory cells; C, antigen-specific effector cells (e.g., cytotoxic T cells).